In this talk, Prof. Mohamed L. Salem presents the importance of having a center of excellence at each institute to enhance and foster scientific research and innovation.
Trans disciplinary research is a must for excellence in science by Prof. Mohamed Labib Salem, Tanta University
1. Cairo University, Egypt
15 October, 2016
Trans-Disciplinary Research Team
Is A Must for Excellence In Science
“Tanta University as a success story”
Mohamed Labib Salem, PhD
Prof. of Immunology
Faculty of Science, Tanta University, Egypt
2. The Talk agenda
1. Research Needs
2. Research Team Works
3. Research Capacity
4. Success Stories
14. Transdisciplinarity integrates the
natural, social and health sciences
in a humanities context, and
transcends their traditional
boundaries.
Transtidisciplinary Research Team
23. Transdisciplinary leaderships
1- Effective cognitive leadership:
Provides a vision that links and
motivates transdisciplinary
researchers to step beyond their
disciplinary lens, relax old
assumptions, and search for
creative frame-breaking solutions.
34. Grants, Innovation & Technology Transfer Center
• Technology Transfer Office (TTO)
• Grants and International
Cooperation Office (GICO)
• Technology Innovation Support
Center (TISC)
38. • Tanta University Central Lab (5m LE; STDF)
• Tanta University CECR (10m LE; STDF)
• Faculty of Medicine (7m; 3 projects; STDF)
• Faculty of Science (4 projects; 6m; STDF)
• Faculty of Agriculture (1 project; Mobility, FP7)
• Faculty of Engineering (5 projects, 10m; STDF)
• Ministry of Int Cooperation (about 1m)
• Academy of Scientific Research & Technology (2m)
• Ministry of Higher Education (about 10m)
Medicine, Engineering, Science, Education
National and International Grants
40. STDF Grants for Centers of Scientific Excellence (STDF-CSE)
السرطان ألبحاث التميز مركز
CENTER OF EXCELLENCE IN
CANCER RESEARCH (CECR)
41. Center of Excellence in Cancer Research,
Tanta University
(CECR)
طنطا بجامعة السرطان ألبحاث التميز مركز
42. Established Date
June 2013 through a project funded by Science and
Technology development Fund (STDF)
PI: Prof. Mohamed Labib Salem
Affiliation: Tanta University
Budget: 9,657,500 L.E
Duration: 36 Months
Established Date
43. CECR From Application to Funding
STDF-CSE Call
Proposals
Evaluation
Interview & Oral
Presentation
Site Visit
146 Project
61 Project
25 Project
53. Prof. Mohamed L.Salem
Director, CECR
Prof. Said Hammad
Vice Director, CECR
Prof. Mohamed Ramadan
Clinical Director, CECR
Prof. Mohamed Attia
Director of Flow Cytometry Unit, CECR
Dr. Abdel-Aziz Zidan
Director of Proteomic & Genomic Unit, CECR
Ms. Mona F. Zidan
Research Assistant
Research Team
Eng. Heba M. Wassfy
Coordinator , CECR
Dr. Enas Abdul-Raouf
Research Assistant
56. CECR Vision
Create omic based core facilities
to lead cutting edge translational
cancer research
57. CECR Mission
Create a rich academic environment for
excellence in cancer research to lead the next
generation of scientists and empower the
discovery and entrepreneurships in cancer
prognosis, diagnosis, prevention, and treatment
through efficient collaboration with national and
international esteemed investigators.
58. 1. Establish the CECR to perform cutting-edge
preclinical and clinical research.
2. Correlate immunologic and clinical
performance between genomic,
transcriptomic and proteomic profiling of
circulating tumor cells
Two CECR Main Aims
65. Nomination:
The BD FACSCanto derives its name from the musical term “bel canto” meaning
operatic singing that focuses on ease and purity of tone with an agile and precise
vocal technique.
Flow Cytometry Unit
• BD FACSCanto II Cytometer
66. •
The BD FACSCanto system has a capacity for three lasers, eight-parameter
detection while capturing particle sizes from 0.5 to 50 μm in diameter.
•
Digital electronics for processing up to 10,000 events per second, and a
novel sample injection tube supporting
Multiparameter detection helps in:
•
Advanced cell subset analysis.
•
Multiparameter functional studies.
•
Soluble protein detection.
•
Quantification studies for cell-surface antigens and soluble proteins.
•
Decreases the total sample volume necessary for a specific project as more
parameters.
Specifications of the instrument
Specifications of the instrument
68. Stem cell
enumeration
Detection of minimal
residual disease
BD FACSCanto Applications
Analysis of
Leukemias and
Lymphomas
Reticulocyte
analysis
Detection of
Immunodeficiency
diseases
Detection of
HIV infection
Analysis of
different types of
solid tumors.
Detection of
autoantibodies
Research & Clinical applications of the instrument
BD FACSCanto Applications
70. The IsoFlux system enriches rare cells from biological samples and
prepare them for further analysis , It gives immediate access to high-
quality , viable cells in a high density format , ready for use in the
application of your choice
Cell Sorting Unit
71. Cell Sorting Unit
IsoFlux Applications
Enumeration Immunofluorescence
Fluorescence in
situ hybridization
Next generation
sequencing
Mutation
detection
Gene
expression
76. Genomic Unit
Microarray Applications
Transciptome
mRNA Expression
miRNA Expression
Splice Variance
Genome
Structure
DNA Copy number
Genome Variation
Single Nucleotide
Polymorphism
Copy number Variations
Proteome
Protein-Protein Interactions
DNA – Protein intreraction
Epigenetics
DNA Methylation
Chromatin Structure
77. Agilent 2100 Bioanlayzer.
It is the industry standard for RNA
sample QC and has replaced labor-
intensive gel electrophoresis for
this application, It is also rapidly
replacing gel electrophoresis for
DNA fragment analysis and SDS-
PAGE analysis of protein samples.
Genomic Unit
78. Genomic Unit
Bioanalyzer Applications
Whole Cells
RNA
RNA Integrity
RNA Qualification
Small RNA Sizing
DNA
DNA Integrity
DNA Qualification
Protein
Protein Integrity
Protein Qualification
Protein Purity
79. Gel Documentation System
(Biometra Doc Analyze)
Enables simple documentation of
fluorescent and non-fluorescent gels,
membranes, blots, and assays with the
ability to save images to disk for later
quantitative analysis or enhancement for
publication.
Genomic Unit
80. Gene AmpPCR System 9700
It is an automated instrument,
specifically designed for the
amplification of nucleic acids using the
Polymerase Chain Reaction (PCR)
process
Genomic Unit
105. The 1st Annual Conference for the Middle-
Eastern Association of Cancer Research
27-28/12/2011
106.
107. Monday 24 February 2014
The 1st Annual Conference of
The Center of Excellence in Cancer Research
Next Generation Cancer Research & Diagnosis
In Collaboration with
Research Centers of Excellence
(STDF- Affiliated Centers)
CECR Activities
114. CECR Activities
Prof. Mohamed L. Salem’s & Dr. Sohaila Galal’s visit to International 2013
Forum of Immunology. Montreal, Canada
115. CECR Activities
Prof. Gemy Gessy , Prof. of Toxicology, University of Sakatshowan, Canada
Prof. Mohamed Mona, Prof. of Invertebrate Biology, Tanta University
Prof. Elsayed Salem, Prof. of Genetics and Cell Biology, Tanta University
116. CECR Activities: Visitors
Dr Magdy Elhefbawy, President of Gharbia Medical Sector Syndicate
Prof. Gamal Ramadan, Prof. of Immunology, Ain Shams University
118. CECR Activities
Dr. Abdel-Aziz Zidan Training Course on “ Affymetrix Geneship System 3000
7G , Stem Cell Center-Jordan University.
119. CECR Activities
Dr. Abdel-Aziz Zidan Training Course on “ Affymetrix Geneship System 3000
7G , Stem Cell Center-Jordan University.
120. CECR Activities
Mona Zidan’s Training course at International Center for Genetic Engineering
& Biotechnology ICGEB “ Flow Cytometry & Cell Sorting in Biotechnology &
Biomedicine Research” Institut Pasteur de Montevideo, Montevideo, Uruguay
121. CECR Activities
CECR Team Workshop on “The first workshop on Application of bioinformatics
in Molecular Diagnostic Virology” . National Cancer Institute, Cairo University
122. CECR Activities
Dr. Sohaila Galal’s Workshop on “ Gene Expression on Large Scale Using
Microarray and Real time PCR Techniques”. Cairo University Research Park
128. CECR Publications
The Use of Dendritic Cells for Peptide-Based Vaccination in Cancer
Immunotherapy. Mohamed L. Salem
Immunostimulatory Effects of Triggering TLR3 Signaling Pathway
Implication for Cancer Immunotherapy. Mohamed L. Salem, Said M.
Hammad, Mohamed R. Elshanshory, Mohamed A. Attia, Abdel-Aziz A. Zidan.
G-CSF/anti-G-CSF antibody complexes drive the potent recovery
and expansion of CD11b+Gr-1+ myeloid cells without
compromising CD8+ T cell immune responses. Mark P Rubinstein,
Mohamed L Salem, Andrew L Doedens, Caitlin J Moore, cody Chiuzan, Guillermo L
Rivell, David J Cole and Ananda W Goldrath
129. CECR Publications
Understanding the biology of ex vivo-expanded CD8 T cells for
adoptive cell therapy: role of CD62L Immunol Res. Díaz-Montero CM,
Zidan AA, Pallin MF, Anagnostopoulos V, Mohamed L Salem, Wieder E, Komanduri
K, Montero AJ, Lichtenheld MG
Immunobiology and signaling pathways of cancer stem cells:
implication for cancer therapy. Salem ML, El-Badawy AS, Li Z
Autologous transplantation of CD34+ bone marrow derived
mononuclear cells in management of non-reconstructable critical
lower limb ischemia. Ismail AM1, Abdou SM, Aty HA, Kamhawy AH, Elhinedy
M, Elwageh M, Taha A, Ezzat A, Salem HA, Youssif S, Salem ML
130. CECR Publications
IL-12 enhances the function and anti-tumor activity in murine and
human CD8+ T cells. Mark P. Rubinstein, Ee Wern Su, Samantha Suriano,
Colleen A. Cloud, Kristina Andrijauskaite, Pravin Kesarwani, Kristina M. Schwartz,
Katelyn Williams, C. Bryce Johnson, Mingli Li, Gina M. Scurti, Mohamed L. Salem,
Chrystal M. Paulos, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Michael I.
Nishimura, and David J
132. CECR Students
9 PhD Students
15 MSc Students
Adaptive Cell Therapy
Cancer Biology
Anti Cancer effects of medicinal Plans
Stem Call based therapy
Cancer Stem cells
Immunoregulatory cells
Hurdles and solutions in CTC research.
Biophysical factors that may diminish the detection of CTCs include (A) filtration of large CTCs in smaller capillaries, (B)clustering of tumor cells that lodge in capillaries, and (C)cloaking of CTCs by platelets or coagulation factors. Biological factors that likely complicate the detection and isolation of clinically relevant populations of CTCs that currently rely on epithelial markers include (D) the presence of benign circulating epithelial cells, (E) the large heterogeneity among CTCs, (F) the possible stemness of a subpopulation of CTCs, (G) the (partial) epithelial-mesenchymal transition (EMT) that some CTCs undergo during dissemination, and (H) the unclear seeding potential of detected CTCs. Future research should use technologies focused on (I) improving the detection and isolation of CTCs, and (J) single-cell “omics.”
MiSeq™, a low-cost personal sequencing system that leverages the company’s proven TruSeq Sequencing chemistry to offer individual researchers a platform with rapid turnaround time, unmatched accuracy, and the easiest to use workflow.